Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)
Clinical trial NCT03252717 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03252717
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2017-08-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.